Cargando…
COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis
New strategies and drugs are urgently needed to improve the treatment of hepatocellular carcinoma (HCC). Vasculogenic mimicry (VM) has been elucidated being associated with the progression of HCC and anti-VM could be a promising strategy. Celastrus orbiculatu s extract (COE), a mixture of 26 compoun...
Autores principales: | Chu, Zewen, Shi, Xin, Chen, Gaoyang, He, Xuejun, Qian, Yayun, Wang, Haibo, Tao, Li, Liu, Yanqing, Jiang, Wei, Chen, Jue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044863/ https://www.ncbi.nlm.nih.gov/pubmed/33867982 http://dx.doi.org/10.3389/fphar.2021.619732 |
Ejemplares similares
-
Corrigendum: COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis
por: Chu, Zewen, et al.
Publicado: (2022) -
Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K
por: Wang, Hua, et al.
Publicado: (2016) -
miR-141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression
por: Li, Guoxiong, et al.
Publicado: (2018) -
Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma
por: Kim, Hee Sung, et al.
Publicado: (2019) -
Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion
por: Jue, Chen, et al.
Publicado: (2016)